First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors.

Gerald Falchook, Yongmei Yin, R. Donald Harvey, Siqing Fu, Weitao Yao, Yanru Qin, Xiaojing Zhang, Qingping Zou, Boyao Shan, Pan Liang, Chen Wang, Wenjia Li, Zehra Nurgul Pamuklar, Yi Pei, Zhiwei Chang, Jiaqiang Wang, Sarina A. Piha-Paul, Manali Bhave, Yan Liang, Jason Timothy Henry